Status unknownNCT05810844Updated Apr 12, 2023

Comparison Of Effects of MRP Vs NDT For Balance and Gait in Chronic Ischemic Stroke Patients RCT

An interventional study of Motor Relearning Program (MRP) and Neuro Development Treatment (NDT) in Stroke, sponsored by Superior University. Status unknown. Open to participants aged 45 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-04-12.

Sponsored by Superior University · Not applicable, Interventional, and Health services research

The sponsor has not verified this record recently (last verified Mar 2023), so the status shown — last known as Not yet recruiting — may be out of date.

Phase: Not applicable
Study type: Interventional
Enrollment: 40
Allocation: Randomized
Ages: 45 Years to 65 Years
Sex: All

Study summary

To determine the comparison between effects of Motor Relearning Program (MRP) and Neuro-Development Treatment (NDT) on balance and gait in chronic ischemic stroke patients.

Conditions studied

Stroke

Browse trials for

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's planned enrollment of 40 is below the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Superior University is the lead sponsor of 242 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 45 Years to 65 Years
Sexes eligible: All
Accepts healthy volunteers: No

Inclusion criteria

Chronic ischemic stroke Patients more than 6 months. (55)
Patient with good cognitive status minimum 20 or greater out of 30 in Mini mental state examinations.(56)
Age between 45-65 years.(57)
Patient with limb spasticity equal to 2 or less than 2 on Modified Ashworth scale.(56)
Both male and female patients.(58)

Exclusion criteria

Exclusion Criteria:

History of neurologic disease(59, 60)
History of lower limb fracture.(61)
History of spinal cord fracture.(61)
Patient with skin discoloration, skin ulcers and skin allergy.(62)
Patients with a history of the recurrent stroke. (63)
Patients with any peripheral vascular disease.(60)

Study design

Phase: Not applicable
Primary purpose: Health services research
Allocation: Randomized
Intervention model: Parallel assignment
Masking: None (open label)
Enrollment: 40 participants (estimated)

Study arms

Experimental
Motor Relearning Program (MRP)
Diagnostic Test: Motor Relearning Program (MRP)
Experimental
Neuro Development Treatment (NDT)
Diagnostic Test: Neuro Development Treatment (NDT)

Interventions

Diagnostic testMotor Relearning Program (MRP)
MRP technique with a conventional physiotherapy treatment. Conventional physiotherapy treatment will help to reduce the functional impairments in chronic ischemic stroke
Diagnostic testNeuro Development Treatment (NDT)
Neuro-Development Treatment NDT as well as conventional treatment. Conventional physiotherapy treatment will help to reduce the functional impairments in chronic ischemic stroke patients

What researchers measure

Primary outcomes

Effects of Motor Relearning Program Techinique, Neuro Development Treatment Techinique
Time frame: 6 Months

Study locations

No study locations are listed for this record.

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

Updates

Tracking since Sep 25, 2026

No changes since tracking began. The registry record was last updated on Apr 12, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT05810844
Lead sponsor: Superior University
Responsible party: Muhammad Naveed Babur (Principal Investigator, Superior University) — Principal investigator
First posted: Apr 12, 2023
Start date: Apr 1, 2023 (estimated)
Primary completion: Jun 1, 2023 (estimated)
Completion: Aug 31, 2023 (estimated)
Last update: Apr 12, 2023

Oversight

Data monitoring committee: Yes
FDA-regulated drug: No
FDA-regulated device: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Stroke→

Other studies from this sponsor

Superior University

Start the discussion